Contracepção para adolescentes com doenças reumáticas crônicas

Revista Brasileira de Reumatologia - Tập 57 - Trang 73-81 - 2017
Benito Lourenço1, Katia T. Kozu2, Gabriela N. Leal3, Marco F. Silva2, Elisabeth G.C. Fernandes2, Camila M.P. França2, Fernando H.C. Souza4, Clovis A. Silva1,2,4
1Universidade de São Paulo (USP), Faculdade de Medicina, Unidade do Adolescente, São Paulo, SP, Brasil
2Universidade de São Paulo (USP), Faculdade de Medicina, Unidade de Reumatologia Pediátrica, São Paulo, SP, Brasil
3Universidade de São Paulo (USP), Faculdade de Medicina, Unidade de Radiologia, São Paulo, SP, Brasil
4Universidade de São Paulo (USP), Faculdade de Medicina, Divisão de Reumatologia, São Paulo, SP, Brasil

Tài liệu tham khảo

WHO. The adolescent with a chronic condition. 2007 [Accessado em 15 junho 2015]. Disponível em: http://www.who.int/maternal_child_adolescent/documents/9789241595704/en/ National Survey of Children's Health. NSCH 2011/12. Data query from the Child and Adolescent Health Measurement Initiative, Data Resource Center for Child and Adolescent Health website. [Accessado em 7 junho 2015]. Disponível em: http://childhealthdata.org/browse/survey/results?q=2473&r=1&g=448. Pires, 2014, Preventing adolescent pregnancy: biological, social, and political influences on age at first sexual intercourse, J Primary Prevent, 35, 239, 10.1007/s10935-014-0344-5 Oliveira-Campos, 2013, Contextual factors associated with sexual behavior among Brazilian adolescents, Annals of Epidemiology, 23, 629, 10.1016/j.annepidem.2013.03.009 Shafii, 2007, Association between condon use at sexual debut and subsequent sexual trajetories: a longitudinal study using biomarkers, Am J Public Health, 97, 1090, 10.2105/AJPH.2005.068437 WHO. WHO Guidelines on Preventing Early Pregnancy and Poor Reproductive Outcomes Among Adolescents in Developing Countries. 2011 [Accessado 10 junho 2015]. Disponível em: http://whqlibdoc.who.int/publications/2011/9789241502214_eng.pdf?ua=1 WHO. Adolescent Pregnancy. Fact Sheet 364 [accessado 5 julho 2015]. Disponível em: http://www.who.int/mediacentre/factsheets/fs364/en/ Paranjothy, 2009, Teenage pregnancy: who suffers?, Arch Dis Child, 94, 239, 10.1136/adc.2007.115915 Malabarey, 2012, Pregnancies in young adolescent mothers: a population‐based study on 37 million births, J Pediatr Adolesc Gynecol, 25, 98, 10.1016/j.jpag.2011.09.004 Ganchimeg, 2014, Pregnancy and childbirth outcomes among adolescent mothers: a World Health Organization multicountry study, BJOG, 121, 40, 10.1111/1471-0528.12630 Greydanus, 2012, Concepts of contraception for adolescent and young adult women with chronic illness and disability, Dis Mon, 58, 258, 10.1016/j.disamonth.2012.02.001 Hartman, 2012, Adolescent contraception: review and guidance for pediatric clinicians, Curr Probl Pediatr Adolesc Health Care, 42, 221, 10.1016/j.cppeds.2012.05.001 Silva, 2008, Pregnancy outcome in juvenile systemic lupus erythematosus: a Brazilian multicenter cohort study, J Rheumatol, 35, 1414 Chacravarty, 2014, Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives, BMJ Open, 4, e004081, 10.1136/bmjopen-2013-004081 Oringanje, 2009, Interventions for preventing unintended pregnancies among adolescentes, Cochrane Database Syst Rev, 4, CD005215 Kann, 2014, Youth Risk Behavior Surveillance — United States, 2013, MMWR, 63, 1 Kost, 2008, Estimates of contraceptive failure from the 2002 National Survey of Family Growth, Contraception, 77, 10, 10.1016/j.contraception.2007.09.013 WHO. Medical eligibility criteria for contraceptive use. 5th ed. Genebra OMS; 2015 [acessado em 15 junho de 2015]. Disponível em http://www.who.int/reproductivehealth/publications/family_planning/Ex‐Summ‐MEC‐5/en/ Centers for Disease Control and Prevention. Medical Eligibility Criteria for Contraceptive Use, 2010. Adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition. MMWR 2010;59 (No.RR‐4):1‐86. Silva, 2012, Taxonomy for systemic lupus erythematosus with onset before adulthood, Arthritis Care Res (Hoboken), 64, 1787, 10.1002/acr.21757 Yazdany, 2011, Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?, Arthritis Care Res, 63, 358 Silva, 2007, Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study, Lupus, 16, 531, 10.1177/0961203307079300 Tucker, 2008, Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case‐control study within LUMINA, a multiethnic US cohort (LUMINA LVII), Lupus, 17, 314, 10.1177/0961203307087875 Gormezano, 2015, Higher Prevalence and Distinct Features of Herpes Zoster Infection in Children than Adults with Systemic Lupus Erythematosus, Pediatr Infect Dis J., 34, 905, 10.1097/INF.0000000000000756 Petri, 2008, Sex hormones and systemic lupus erythematosus, Lupus, 17, 412, 10.1177/0961203308090026 Grimaldi, 2006, Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells, Curr Opin Rheumatol., 18, 456, 10.1097/01.bor.0000240354.37927.dd Stegeman, 2013, Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta‐analysis, BMJ, 347, 5298, 10.1136/bmj.f5298 Petri, 2005, Combined oral contraceptives in women with systemic lupus erythematosus, N Engl J Med, 353, 2550, 10.1056/NEJMoa051135 Sanchez-Guerrero, 2005, A trial of contraceptive methods in women with systemic lupus erythematosus, N Eng J Med, 353, 2539, 10.1056/NEJMoa050817 1995, Venous thromboembolic disease and combined oral contraceptives: Rrsults of international multicenter case‐control study, Lancet, 346, 1575, 10.1016/S0140-6736(95)91926-0 Culwell, 2009, Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review, Obstet Gynecol., 114, 341, 10.1097/AOG.0b013e3181ae9c64 Tesher, 2010, Contraception for adolescents with lupus, Pediatr Rheumatol Online J, 8, 10, 10.1186/1546-0096-8-10 Mintz, 1984, Contraception with progestagens in systemic lupus erythematosus, Contraception, 30, 29, 10.1016/0010-7824(84)90076-3 Julkunen, 1993, Contraceptive practice in women with systemic lupus erythematosus, Br J Rheumatol, 32, 227, 10.1093/rheumatology/32.3.227 Vasilakis, 1999, Risk of idiopathic venous thromboembolism in users of progestagens alone, Lancet., 354, 1610, 10.1016/S0140-6736(99)04394-9 Cromer, 2006, Society for Adolescent Medicine. Depot medroxyprogesterone acetate and bone mineral density in adolescents ‐ The Black Box warning: a position paper of the Society for Adolescent Medicine, J Adolesc Health, 39, 296, 10.1016/j.jadohealth.2006.03.011 Finer, 2012, Changes in use of long‐acting contraceptive methods in the United States, 2007‐2009, Fertil Steril, 98, 893, 10.1016/j.fertnstert.2012.06.027 Mc Nicholas, 2012, Long‐acting reversible contraception for adolescents, Curr Opin Obstet Gynecol, 24, 293, 10.1097/GCO.0b013e32835686d5 Peipert, 2011, Continuation and satisfaction of reversible contraception, Obstet Gynecol, 117, 1105, 10.1097/AOG.0b013e31821188ad Mohllajee, 2006, Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review, Contraception, 73, 145, 10.1016/j.contraception.2005.08.007 Lakasing, 2001, Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: What advice should we be giving, J Fam Plann Reprod Health Care, 27, 7, 10.1783/147118901101195029 Vad, 2003, Antiphospholipid antibodies in young women with and without oral contraceptive use, Blood Coag Fibrinolys, 14, 57, 10.1097/00001721-200301000-00010 Asherson, 1988, Complications of oral contraceptives and antiphospholipid antibodies, Arthritis Rheum, 31, 575, 10.1002/art.1780310424 Choojitarom, 2008, Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies, Clin Rheumatol, 27, 345, 10.1007/s10067-007-0721-z Wahl, 1997, Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—a meta‐analysis, Lupus., 6, 467, 10.1177/096120339700600510 Mantha, 2012, Assessing the risk of venous thromboembolic events in women taking progestin‐only contraception: a meta‐analysis, BMJ, 345, e4944, 10.1136/bmj.e4944 Tincani, 2007, Contraception in adolescents with systemic lupus erythematosus, Lupus, 16, 600, 10.1177/0961203307078074 Yamakami, 2014, Ovarian reserve in women with primary antiphospholipid syndrome, Lupus, 23, 862, 10.1177/0961203314529468 Yamakami, 2011, Severe hemorrhagic corpus luteum complicating anticoagulation in antiphospholipid syndrome, Lupus., 20, 523, 10.1177/0961203310383300 Schaedel, 2005, The use of the levonorgestrel‐releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders, Am J Obstet Gynecol, 193, 1361, 10.1016/j.ajog.2005.05.002 Britto, 2000, Improving rheumatologists’ creening for alcohol use and sexual activity, Arch Pediatr Adolesc Med, 154, 478, 10.1001/archpedi.154.5.478 Chen, 2013, Pregnancy outcomes in women with juvenile idiopathic arthritis: a population‐based study, Rheumatology (Oxford), 52, 1119, 10.1093/rheumatology/kes428 Vancsa, 2007, Pregnancy outcome in idiopathic inflammatory myopathy, Rheumatol Int, 27, 435, 10.1007/s00296-006-0239-8 2012, Committee on Adolescence. Emergency contraception, Pediatrics, 130, 1174, 10.1542/peds.2012-2962 Armstrong, 2010, ACOG Recommendations on Emergency Contraception, Am Fam Physician, 82, 1278 Hadorn, 1996, Rating the quality of evidence for clinical practice guidelines, J Clin Epidemiol, 49, 749, 10.1016/0895-4356(96)00019-4